Incidence of and risk factors for postoperative nausea and vomiting at a Japanese Cancer Center: first large-scale study in Japan [PDF]
, 2012 MORINO Ryozo +3 more
core +2 more sources
Safety and antiemetic efficacy of weekly administration of netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant chemo-radiotherapy-the DANGER-emesis study. [PDF]
Support Care CancerDetlefsen SS +8 more
europepmc +1 more source
Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting. [PDF]
Future OncolNavari RM +7 more
europepmc +1 more source
Palonosetron Improves Dietary Intake Compared to Granisetron in Patients Undergoing Highly Emetogenic Chemotherapy [PDF]
, 2013 Nobuhiro Shibata +7 more
openalex +1 more source
Successful re-administration after nano-liposomal irinotecan-induced severe hypersensitivity reaction: a case report. [PDF]
J Pharm Health Care SciKanno R +5 more
europepmc +1 more source
Expert Consensus Guidance on the Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective. [PDF]
CureusDhabhar B +10 more
europepmc +1 more source
Effect of closed-chain isometric plyometric training combined with palonosetron on postoperative knee function in patients after total knee arthroplasty. [PDF]
Front SurgShao J +5 more
europepmc +1 more source
Transdermal Granisetron Versus Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting Following Moderately Emetogenic Chemotherapy (Mec): a Multicenter, Randomized, Open-Label, Cross-Over, Active-Controlled, Phase Iv Study [PDF]
, 2014 Young Mi Seol
openalex +1 more source